#45FUZKK atlas leaders 1–100

Duopharma Biotech

Malaysia · Southeast Asia

Biologics

Manufacturing profile

Biologics

Country: Malaysia

Macro-region: Southeast Asia

Selection basis

The company is placed in positions 1–100 as a major manufacturer, biopharmaceutical group, generics/API/CDMO leader or a significant regional manufacturing participant.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Representative manufacturing and QC chain

  1. 1Cell bank or microbial seed
  2. 2Upstream culture or fermentation
  3. 3Clarification and chromatography
  4. 4UF/DF, formulation and sterile filtration
  5. 5SEC, CE, LC-MS, ELISA, qPCR and bioassay QC

Relevant FUZKK packages

Lumex — instrumental QC

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Methodology